Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Acute Flaccid Myelitis (AFM): What Health Care Providers Need to Know

Image of Continuing Education Credits abbreviation. = Free Continuing Education

Date: Tuesday, November 13, 2018

Time: 2:00pm-3:00pm (Eastern Time)

Instructions for Obtaining Continuing Education (CE)
To receive continuing education (CE) for WC2922-111318 – (Webcast) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Acute Flaccid Myelitis (AFM): What Health Care Providers Need to Know – November 13, 2018, 2018, please visit TCEO and follow these 9 Simple Steps by December 17, 2018.

To receive continuing education (CE) for WD2922-111318 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Acute Flaccid Myelitis (AFM): What Health Care Providers Need to Know – November 13, 2018 (Web on Demand), please visit TCEO and follow these 9 Simple Steps by December 18, 2020.

Overview

The Centers for Disease Control and Prevention (CDC) is actively investigating acute flaccid myelitis, or AFM, a serious condition that causes weakness in the arms or legs. From August 2014 through October 2018, CDC has received information on a total of 396 confirmed cases of AFM across the US; most of the cases have occurred in children. As of October 26, there are 72 confirmed cases of AFM so far in 2018. The patients’ symptoms have been most similar to complications of infection with certain viruses, including poliovirus, non-polio enteroviruses, adenoviruses, and West Nile virus. CDC has not confirmed the cause for the majority of these cases.

During this COCA call, subject matter experts from CDC will highlight the importance of reporting cases to learn more about this condition and the process for reporting. They will also cover specimen collection and testing, and what CDC is doing for its AFM investigation.

At the conclusion of the session, the participant will be able to accomplish the following:

  • Identify symptoms of AFM to look for in patients.
  • Explain the process for reporting suspected AFM cases that meet the clinical criteria.
  • List the types of specimens to collect from suspected cases of AFM and where to send them for testing.
  • Discuss the activities CDC is conducting as part of its investigation into AFM.

Call Slides: View Now
Webinar: View Now

Adriana Lopez, MPH
Epidemiologist, Acute Flaccid Myelitis Surveillance Team
Centers for Disease Control and Prevention

Janell Routh, MD, MHS
Medical Officer, Acute Flaccid Myelitis Team
Centers for Disease Control and Prevention

Manisha Patel, MD, MS
Acute Flaccid Myelitis Team Lead
Centers for Disease Control and Prevention

Sarah E. Hopkins, MD, MSPH
Asst. Professor of Clinical Neurology, Section Head, MS and Neuroinflammatory Disorders
Division of Neurology
Children’s Hospital of Philadelphia

  • Webinar/Audio conference call on 11/13/2018: 2:00 – 3:00 PM ET
  • Web-on-demand training a few days after the live call.

Continuing Education

“WC2922” 0387-0000-18-213-L04-P for attendees who participate in the live call (must be completed by December 17, 2018)

“WD2922” 0387-0000-18-213-H04-P for attendees who participate in the online presentation (must be completed by December 18, 2020)

Target Audience

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians

Hardware/Software

Additional Information

  • Contact Information:coca@cdc.gov
  • Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communication Branch
  • Method of Participation:You may participate in the educational activity by viewing the program information above.
  • Fees:COCA continuing education credits are free.

Accreditation Statements

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

Image of acpe logo.CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-18-213-L04-P  and enduring 0387-0000-18-213-H04-P course category.

This activity has been designated as Knowledge-Based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

For Certified Public Health Professionals (CPH)

The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

TOP